Literature DB >> 10426317

Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves.

N P Hoe1, K Nakashima, S Lukomski, D Grigsby, M Liu, P Kordari, S J Dou, X Pan, J Vuopio-Varkila, S Salmelinna, A McGeer, D E Low, B Schwartz, A Schuchat, S Naidich, D De Lorenzo, Y X Fu, J M Musser.   

Abstract

Serotype M1 group A Streptococcus strains cause epidemic waves of human infections long thought to be mono- or pauciclonal. The gene encoding an extracellular group A Streptococcus protein (streptococcal inhibitor of complement) that inhibits human complement was sequenced in 1,132 M1 strains recovered from population-based surveillance of infections in Canada, Finland and the United States. Epidemic waves are composed of strains expressing a remarkably heterogeneous array of variants of streptococcal inhibitor of complement that arise very rapidly by natural selection on mucosal surfaces. Thus, our results enhance the understanding of pathogen population dynamics in epidemic waves and infectious disease reemergence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426317     DOI: 10.1038/11369

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  37 in total

Review 1.  Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions.

Authors:  S D Reid; N P Hoe; L M Smoot; J M Musser
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999.

Authors:  Gregory J Tyrrell; Marguerite Lovgren; Betty Forwick; Nancy P Hoe; James M Musser; James A Talbot
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  Genomic location and variation of the gene for CRS, a complement binding protein in the M57 strains of Streptococcus pyogenes.

Authors:  Michael Binks; David McMillan; Kadaba S Sriprakash
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

4.  Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization.

Authors:  S Lukomski; N P Hoe; I Abdi; J Rurangirwa; P Kordari; M Liu; S J Dou; G G Adams; J M Musser
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Prevalence of a streptococcal inhibitor of a complement-mediated cell lysis-like gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis.

Authors:  Masaaki Minami; Mariko Ichikawa; Hideyuki Matsui; Nanako Hata; Naoki Wakiyama; Masakado Matsumoto; Michio Ohta; Tadao Hasegawa
Journal:  Curr Microbiol       Date:  2010-11-04       Impact factor: 2.188

6.  Serum resistance in an invasive, nontypeable Haemophilus influenzae strain.

Authors:  B J Williams; G Morlin; N Valentine; A L Smith
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  drs (Distantly related sic) gene polymorphisms among emm12-type Streptococcus pyogenes isolates.

Authors:  Claudia M Brandt; Gerhard Haase; Barbara Spellerberg; Regina Holland; Rudolf Lütticken
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

8.  Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence.

Authors:  Stephen B Beres; Gail L Sylva; Kent D Barbian; Benfang Lei; Jessica S Hoff; Nicole D Mammarella; Meng-Yao Liu; James C Smoot; Stephen F Porcella; Larye D Parkins; David S Campbell; Todd M Smith; John K McCormick; Donald Y M Leung; Patrick M Schlievert; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

9.  Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes.

Authors:  Jovanka M Voyich; Daniel E Sturdevant; Kevin R Braughton; Scott D Kobayashi; Benfang Lei; Kimmo Virtaneva; David W Dorward; James M Musser; Frank R DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

Review 10.  Antigenic Variation and Immune Escape in the MTBC.

Authors:  Joel D Ernst
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.